213 related articles for article (PubMed ID: 23522381)
1. How does complementary private prescription drug insurance coverage affect seniors' use of publicly funded medications?
Allin S; Law MR; Laporte A
Health Policy; 2013 May; 110(2-3):147-55. PubMed ID: 23522381
[TBL] [Abstract][Full Text] [Related]
2. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.
Kennedy J; Morgan S
Clin Ther; 2009 Jan; 31(1):213-9. PubMed ID: 19243719
[TBL] [Abstract][Full Text] [Related]
3. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Private Insurance Coverage on Prescription Drug Use in Ontario, Canada.
Kratzer J; Cheng L; Allin S; Law MR
Healthc Policy; 2015 May; 10(4):62-74. PubMed ID: 26142359
[TBL] [Abstract][Full Text] [Related]
5. Insurance coverage and the treatment of mental illness: effect on medication and provider use.
Mulvale G; Hurley J
J Ment Health Policy Econ; 2008 Dec; 11(4):177-99. PubMed ID: 19096092
[TBL] [Abstract][Full Text] [Related]
6. How complete are drug history profiles that are based on public drug benefit claims?
Paterson JM; Suleiman A; Hux JE; Bell C
Can J Clin Pharmacol; 2008; 15(1):e108-16. PubMed ID: 18283220
[TBL] [Abstract][Full Text] [Related]
7. Inequity in publicly funded physician care: what is the role of private prescription drug insurance?
Allin S; Hurley J
Health Econ; 2009 Oct; 18(10):1218-32. PubMed ID: 19097042
[TBL] [Abstract][Full Text] [Related]
8. Role of health insurance coverage in women's access to prescription medicines.
Ranji UR; Wyn R; Salganicoff A; Yu H
Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
[TBL] [Abstract][Full Text] [Related]
9. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
Hanley GE; Morgan S
Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
[TBL] [Abstract][Full Text] [Related]
10. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
11. Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data.
McLeod L; Bereza BG; Shim M; Grootendorst P
Open Med; 2011; 5(1):e1-9. PubMed ID: 22046212
[TBL] [Abstract][Full Text] [Related]
12. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
Buttorff C; Andersen MS; Riggs KR; Alexander GC
Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
[TBL] [Abstract][Full Text] [Related]
13. Disparities in prescription drug insurance coverage.
Millar WJ
Health Rep; 1999; 10(4):11-31(ENG); 9-30(FRE). PubMed ID: 10607410
[TBL] [Abstract][Full Text] [Related]
14. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.
Hanley GE; Morgan S; Hurley J; van Doorslaer E
Health Econ; 2008 Dec; 17(12):1379-92. PubMed ID: 18189226
[TBL] [Abstract][Full Text] [Related]
15. A pilot study on cost-related medication nonadherence in Ontario.
Zheng B; Poulose A; Fulford M; Holbrook A
J Popul Ther Clin Pharmacol; 2012; 19(2):e239-47. PubMed ID: 22805096
[TBL] [Abstract][Full Text] [Related]
16. Medicare program; Medicare prescription drug benefit. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
[TBL] [Abstract][Full Text] [Related]
17. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
[TBL] [Abstract][Full Text] [Related]
18. Use of wet nebulized inhaled respiratory medications under criteria-based reimbursement guidelines in a publicly funded Seniors' Pharmacare Program in Nova Scotia, Canada.
Bowles SK; Sketris I; Kephart G;
Am J Geriatr Pharmacother; 2007 Jun; 5(2):120-8. PubMed ID: 17719514
[TBL] [Abstract][Full Text] [Related]
19. The new Medicare drug benefit: much ado about little?
Pauly MV
LDI Issue Brief; 2004; 9(4):1-6. PubMed ID: 15035261
[TBL] [Abstract][Full Text] [Related]
20. Comparison of claims from high-drug cost beneficiaries in Ontario, Canada, and Australia: a cross-sectional analysis.
Tadrous M; Daniels B; Pearson SA; Gomes T
CMAJ Open; 2021; 9(4):E1048-E1054. PubMed ID: 34815260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
